High-density association study of 383 candidate genes for volumetric BMD at the femoral neck and lumbar spine among older men

Journal of Bone and Mineral Research

Volumn 24, Issue 12, 2009, Pages 2039-2049

  Yerges, Laura M ^a   Klei, Lambertus ^b   Cauley, Jane A ^a   Roeder, Kathryn ^c   Kammerer, Candace M ^d   Moffett, Susan P ^a   Ensrud, Kristine E ^e   Nestlerode, Cara S ^a   Marshall, Lynn M ^f   Hoffman, Andrew R ^g   Lewis, Cora ^h   Lang, Thomas F ⁱ   Barrett Connor, Elizabeth ^j   Ferrell, Robert E ^d   Orwoll, Eric S ^f   Zmuda, Joseph M ^a,d  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c CARNEGIE MELLON UNIVERSITY   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^g STANFORD UNIVERSITY   (United States)

^h UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

BMD; Genetics; Men; Osteoporosis; QCT

Indexed keywords

ADULT; AGED; APC GENE; ARTICLE; BMPR1B GENE; BONE DENSITY; COMMUNITY LIVING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DMP1 GENE; FEMUR NECK; FGFR2 GENE; FLT1 GENE; FOXC2 GENE; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HOXA GENE; HUMAN; IGFBP2 GENE; LUMBAR SPINE; MALE; NFATC1 GENE; PTN GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SOST GENE;

BONE DENSITY; FEMUR; GENE EXPRESSION PROFILING; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LUMBAR VERTEBRAE; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 73849131430     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.090524     Document Type: Article

References (75)

1. Riggs BL, Melton LJ III 1995 The worldwide problem of osteoporosis: Insights afforded by epidemiology. Bone 17(Suppl):505S-511S.
2. Silverman SL 2005 Quality-of-life issues in osteoporosis. Curr Rheumatol Rep 7:39-45.
3. Anonymous 2001 Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785-795.
4. Ralston SH, de Crombrugghe B 2006 Genetic regulation of bone mass and susceptibility to osteoporosis. Genes Dev 20:2492-2506.
5. Jones G, Nguyen TV 2000 Associations between maternal peak bone mass and bone mass in prepubertal male and female children. J Bone Miner Res 15:1998-2004.
6. Richards JB, Rivadeneira F, Inouye M, Pastinen TM, Soranzo N, Wilson SG, Andrew T, Falchi M, Gwilliam R, Ahmadi KR, Valdes AM, Arp P, Whittaker P, Verlaan DJ, Jhamai M, Kumanduri V, Moorhouse M, van Meurs JB, Hofman A, Pols HA, Hart D, Zhai G, Kato BS, Mullin BH, Zhang F, Deloukas P, Uitterlinden AG, Spector TD 2008 Bone mineral density, osteoporosis, and osteoporotic fractures: A genome-wide association study. Lancet 371:1505-1512.
7. Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, Gudbjartsson DF, Walters GB, Ingvarsson T, Jonsdottir T, Saemundsdottir J, Center JR, Nguyen TV, Bagger Y, Gulcher JR, Eisman JA, Christiansen C, Sigurdsson G, Kong A, Thorsteinsdottir U, Stefansson K 2008 Multiple genetic loci for bone mineral density and fractures. N Engl J Med 358:2355-2365.
8. Zmuda JM, Kammerer CM 2008 Snipping away at osteoporosis susceptibility. Lancet 371:1479-1480.
9. Carter DR, Bouxsein ML, Marcus R 1992 New approaches for interpreting projected bone densitometry data. J Bone Miner Res 7:137-145.
10. Reid IR, Evans MC, Ames R, Wattie DJ 1991 The influence of osteophytes and aortic calcification on spinal mineral density in postmenopausal women. J Clin Endocrinol Metab 72:1372-1374.
11. Yu W, Gluer CC, Fuerst T, Grampp S, Li J, Lu Y, Genant HK 1995 Influence of degenerative joint disease on spinal bone mineral measurements in postmenopausal women. Calcif Tissue Int 57:169-174.
12. Liu G, Peacock M, Eilam O, Dorulla G, Braunstein E, Johnston CC 1997 Effect of osteoarthritis in the lumbar spine and hip on bone mineral density and diagnosis of osteoporosis in elderly men and women. Osteoporos Int 7:564-569.
13. Orwoll ES, Oviatt SK, Mann T 1990 The impact of osteophytic and vascular calcifications on vertebral mineral density measurements in men. J Clin Endocrinol Metab 70:1202-1207.
14. Orwoll E, Blank JB, Barrett-Connor E, Cauley J, Cummings S, Ensrud K, Lewis C, Cawthon PM, Marcus R, Marshall LM, McGowan J, Phipps K, Sherman S, Stefanick ML, Stone K 2005 Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study - a large observational study of the determinants of fracture in older men. Contemp Clin Trials 26:569-585.
15. Blank JB, Cawthon PM, Carrion-Petersen ML, Harper L, Johnson JP, Mitson E, Delay RR 2005 Overview of recruitment for the osteoporotic fractures in men study (MrOS). Contemp Clin Trials 26:557-568.
16. Marshall LM, Lang TF, Lambert LC, Zmuda JM, Ensrud KE, Orwoll ES 2006 Dimensions and volumetric BMD of the proximal femur and their relation to age among older U.S. men. J Bone Miner Res 21:1197-1206.
17. International HapMap Consortium 2003 The International HapMap Project. Nature 426:789-796.
18. Roeder K, Bacanu SA, Sonpar V, Zhang X, Devlin B 2005 Analysis of single-locus tests to detect gene/disease associations. Genet Epidemiol 28:207-219.
19. Zhao T, Chang LW, McLeod HL, Stormo GD 2004 Promo-Lign: A database for upstream region analysis and SNPs. Hum Mutat 23:534-539.
20. Conde L, Vaquerizas JM, Santoyo J, Al-Shahrour F, Ruiz-Llorente S, Robledo M, Dopazo J 2004 PupaSNP finder: A web tool for finding SNPs with putative effect at transcriptional level. Nucleic Acids Res 32:W242-W248.
21. Cardon LR, Bell JI 2001 Association study designs for complex diseases. Nat Rev Genet 2:91-99.
22. Falush D, Stephens M, Pritchard JK 2003 Inference of population structure using multilocus genotype data: Linked loci and correlated allele frequencies. Genetics 164:1567-1587.
23. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D 2006 Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38:904-909.
24. Havill LM, Mahaney MC, Binkley TL, Specker BL 2007 Effects of genes, sex, age, and activity on BMC, bone size, and areal and volumetric BMD. J Bone Miner Res 22:737-746.
25. Wang X, Kammerer CM, Wheeler VW, Patrick AL, Bunker CH, Zmuda JM 2007 Genetic and environmental determinants of volumetric and areal BMD in multi-generational families of African ancestry: The Tobago Family Health Study. J Bone Miner Res 22:527-536.
26. Yamada Y, Ando F, Shimokata H 2006 Association of polymorphisms in forkhead box C2 and perilipin genes with bone mineral density in community-dwelling Japanese individuals. Int J Mol Med 18:119-127.
27. Balemans W, Ebeling M, Patel N, Van Hul E, Olson P, Dioszegi M, Lacza C, Wuyts W, Van Den Ende J, Willems P, Paes-Alves AF, Hill S, Bueno M, Ramos FJ, Tacconi P, Dikkers FG, Stratakis C, Lindpaintner K, Vickery B, Foernzler D, Van Hul W 2001 Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet 10:537-543.
28. Brunkow ME, Gardner JC, Van Ness J, Paeper BW, Kovacevich BR, Proll S, Skonier JE, Zhao L, Sabo PJ, Fu Y, Alisch RS, Gillett L, Colbert T, Tacconi P, Galas D, Hamersma H, Beighton P, Mulligan J 2001 Bone dysplasia sclerosteosis results fromloss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet 68:577-589.
29. Uitterlinden AG, Arp PP, Paeper BW, Charmley P, Proll S, Rivadeneira F, Fang Y, van Meurs JB, Britschgi TB, Latham JA, Schatzman RC, Pols HA, Brunkow ME 2004 Polymorphisms in the sclerosteosis/van Buchem disease gene (SOST) region are associated with bone-mineral density in elderly whites. Am J Hum Genet 75:1032-1045.
30. Tacconi P, Ferrigno P, Cocco L, Cannas A, Tamburini G, Bergonzi P, Giagheddu M 1998 Sclerosteosis: Report of a case in a black African man. Clin Genet 53:497-501.
31. Munemitsu S, Albert I, Souza B, Rubinfeld B, Polakis P 1995 Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci USA 92:3046-3050.
32. Westendorf JJ, Kahler RA, Schroeder TM 2004 Wnt signaling in osteoblasts and bone diseases. Gene 341:19-39.
33. Monaghan H, Bubb VJ, Sirimujalin R, Millward-Sadler SJ, Salter DM 2001 Adenomatous polyposis coli (APC), beta-catenin, and cadherin are expressed in human bone and cartilage. Histopathology 39:611-619.
34. Holmen SL, Zylstra CR, Mukherjee A, Sigler RE, Faugere MC, Bouxsein ML, Deng L, Clemens TL, Williams BO 2005 Essential role of beta-catenin in postnatal bone acquisition. J Biol Chem 280:21162-21168.
35. Newman SA 1996 Sticky fingers: Hox genes and cell adhesion in vertebrate limb development. Bioessays 18:171-174.
36. Hassan MQ, Tare R, Lee SH, Mandeville M, Weiner B, Montecino M, van Wijnen AJ, Stein JL, Stein GS, Lian JB 2007 HOXA10 controls osteoblastogenesis by directly activating bone regulatory and phenotypic genes. Mol Cell Biol 27:3337-3352.
37. Gersch RP, Lombardo F, McGovern SC, Hadjiargyrou M 2005 Reactivation of Hox gene expression during bone regeneration. J Orthop Res 23:882-890.
38. Ling Y, Rios HF, Myers ER, Lu Y, Feng JQ, Boskey AL 2005 DMP1 depletion decreases bone mineralization in vivo: An FTIR imaging analysis. J Bone Miner Res 20:2169-2177.
39. Feng JQ, Ward LM, Liu S, Lu Y, Xie Y, Yuan B, Yu X, Rauch F, Davis SI, Zhang S, Rios H, Drezner MK, Quarles LD, Bonewald LF, White KE 2006 Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet 38:1310-1315.
40. Qin C, D'Souza R, Feng JQ 2007 Dentin matrix protein 1 (DMP1): New and important roles for biomineralization and phosphate homeostasis. J Dent Res 86:1134-1141.
41. Rios HF, Ye L, Dusevich V, Eick D, Bonewald LF, Feng JQ 2005 DMP1 is essential for osteocyte formation and function. J Musculoskelet Neuronal Interact 5:325-327.
42. Beamer WG, Shultz KL, Churchill GA, Frankel WN, Baylink DJ, Rosen CJ, Donahue LR 1999 Quantitative trait loci for bone density in C57BL/6J and CAST/EiJ inbred mice. Mamm Genome 10:1043-1049.
43. Xiong Q, Han C, Beamer WG, Gu W 2008 A close examination of genes within quantitative trait loci of bone mineral density in whole mouse genome. Crit Rev Eukaryot Gene Expr 18:323-343.
44. Wilkie AO 2005 Bad bones, absent smell, selfish testes: The pleiotropic consequences of human FGF receptor mutations. Cytokine Growth Factor Rev 16:187-203.
45. Ratisoontorn C, Fan GF, McEntee K, Nah HD 2003 Activating (P253R, C278F) and dominant negative mutations of FGFR2: Differential effects on calvarial bone cell proliferation, differentiation, and mineralization. Connect Tissue Res 44(Suppl 1):292-297.
46. Matsumoto Y, Tanaka K, Hirata G, Hanada M, Matsuda S, Shuto T, Iwamoto Y 2002 Possible involvement of the vascular endothelial growth factor-Flt-1-focal adhesion kinase pathway in chemotaxis and the cell proliferation of osteoclast precursor cells in arthritic joints. J Immunol 168:5824-5831.
47. Nakagawa M, Kaneda T, Arakawa T, Morita S, Sato T, Yomada T, Hanada K, Kumegawa M, Hakeda Y 2000 Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts. FEBS Lett 473:161-164.
48. Niida S, Kaku M, Amano H, Yoshida H, Kataoka H, Nishikawa S, Tanne K, Maeda N, Kodama H 1999 Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption. J Exp Med 190:293-298.
49. Ren WP, Markel DC, Zhang R, Peng X, Wu B, Monica H, Wooley PH 2006 Association between UHMWPE particle-induced inflammatory osteoclastogenesis and expression of RANKL, VEGF, and Flt-1 in vivo. Biomaterials 27:5161-5169.
50. Deckers MM, Karperien M, van der Bent C, Yamashita T, Papapoulos SE, Lowik CW 2000 Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology 141:1667-1674.
51. Otomo H, Sakai A, Uchida S, Tanaka S, Watanuki M, Moriwaki S, Niida S, Nakamura T 2007 Flt-1 tyrosine kinase-deficient homozygous mice result in decreased trabecular bone volume with reduced osteogenic potential. Bone 40:1494-1501.
52. Yang X, Tare RS, Partridge KA, Roach HI, Clarke NM, Howdle SM, Shakesheff KM, Oreffo RO 2003 Induction of human osteoprogenitor chemotaxis, proliferation, differentiation, and bone formation by osteoblast stimulating factor-1/ pleiotrophin: Osteoconductive biomimetic scaffolds for tissue engineering. J Bone Miner Res 18:47-57.
53. Tare RS, Oreffo RO, Clarke NM, Roach HI 2002 Pleiotrophin/ Osteoblast-stimulating factor 1: Dissecting its diverse functions in bone formation. J Bone Miner Res 17:2009-2020.
54. Tare RS, Oreffo RO, Sato K, Rauvala H, Clarke NM, Roach HI 2002 Effects of targeted overexpression of pleiotrophin on postnatal bone development. Biochem Biophys Res Commun 298:324-332.
55. Zhao M, Harris SE, Horn D, Geng Z, Nishimura R, Mundy GR, Chen D 2002 Bone morphogenetic protein receptor signaling is necessary for normal murine postnatal bone formation. J Cell Biol 157:1049-1060.
56. Chen D, Zhao M, Mundy GR 2004 Bone morphogenetic proteins. Growth Factors 22:233-241.
57. Nifuji A, Miura N, Kato N, Kellermann O, Noda M 2001 Bone morphogenetic protein regulation of forkhead/winged helix transcription factor Foxc2 (Mfh1) in a murine mesodermal cell line C1 and in skeletal precursor cells. J Bone Miner Res 16:1765-1771.
58. Fisher MC, Meyer C, Garber G, Dealy CN 2005 Role of IGFBP2, IGF-I and IGF-II in regulating long bone growth. Bone 37:741-750.
59. Conover CA, Johnstone EW, Turner RT, Evans GL, John Ballard FJ, Doran PM, Khosla S 2002 Subcutaneous administration of insulin-like growth factor (IGF)-II/IGF binding protein-2 complex stimulates bone formation and prevents loss of bone mineral density in a rat model of disuse osteoporosis. Growth Horm IGF Res 12:178-183.
60. DeMambro VE, Clemmons DR, Horton LG, Bouxsein ML, Wood TL, Beamer WG, Canalis E, Rosen CJ 2008 Gender-specific changes in bone turnover and skeletal architecture in igfbp-2-null mice. Endocrinology 149:2051-2061.
61. Sugimoto T, Nishiyama K, Kuribayashi F, Chihara K 1997 Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures. J Bone Miner Res 12:1272-1279.
62. Shinohara M, Takayanagi H 2007 Novel osteoclast signaling mechanisms. Curr Osteoporos Rep 5:67-72.
63. Stern PH 2006 The calcineurin-NFAT pathway and bone: Intriguing new findings. Mol Interv 6:193-196.
64. Winslow MM, Pan M, Starbuck M, Gallo EM, Deng L, Karsenty G, Crabtree GR 2006 Calcineurin/NFAT signaling in osteoblasts regulates bone mass. Dev Cell 10:771-782.
65. Yuan HY, Chiou JJ, Tseng WH, Liu CH, Liu CK, Lin YJ, Wang HH, Yao A, Chen YT, Hsu CN 2006 FASTSNP: An always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res 34:W635-W641.
66. Lin PI, Vance JM, Pericak-Vance MA, Martin ER 2007 No gene is an island: The flip-flop phenomenon. Am J Hum Genet 80:531-538.
67. Zaykin DV, Shibata K 2008 Genetic flip-flop without an accompanying change in linkage disequilibrium. Am J Hum Genet 82:794-796.
68. Zmuda JM, Cauley JA, Kuller LH, Ferrell RE 2001 A common promotor variant in the cytochrome P450c17alpha (CYP17) gene is associated with bioavailability testosterone levels and bone size in men. J Bone Miner Res 16:911-917.
69. Tofteng CL, Abrahamsen B, Jensen JE, Petersen S, Teilmann J, Kindmark A, Vestergaard P, Gram J, Langdahl BL, Mosekilde L 2004 Two single nucleotide polymorphisms in the CYP17 and COMT Genes - relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy. The Danish Osteoporosis Prevention Study. Calcif Tissue Int 75:123-132.
70. Yamada Y, Ando F, Shimokata H 2005 Association of polymorphisms in CYP17A1, MTP, and VLDLR with bone mineral density in community-dwelling Japanese women and men. Genomics 86:76-85.
71. Chen HY, Chen WC, Hsu CM, Tsai FJ, Tsai CH 2005 Tumor necrosis factor alpha, CYP 17, urokinase, and interleukin 10 gene polymorphisms in postmenopausal women: Correlation to bone mineral density and susceptibility to osteoporosis. Eur J Obstet Gynecol Reprod Biol 122:73-78.
72. Somner J, McLellan S, Cheung J, Mak YT, Frost ML, Knapp KM, Wierzbicki AS, Wheeler M, Fogelman I, Ralston SH, Hampson GN 2004 Polymorphisms in the P450 c17 (17-hydroxylase/ 17,20-Lyase) and P450 c19 (aromatase) genes: Association with serum sex steroid concentrations and bone mineral density in postmenopausal women. J Clin Endocrinol Metab 89:344-351.
73. van Meurs JB, Rivadeneira F, Jhamai M, Hugens W, Hofman A, van Leeuwen JP, Pols HA, Uitterlinden AG 2006 Common genetic variation of the low-density lipoprotein receptor-related protein 5 and 6 genes determines fracture risk in elderly white men. J Bone Miner Res 21:141-150.
74. van Meurs JB, Trikalinos TA, Ralston SH, Balcells S, Brandi ML, Brixen K, Kiel DP, Langdahl BL, Lips P, Ljunggren O, Lorenc R, Obermayer-Pietsch B, Ohlsson C, Pettersson U, Reid DM, Rousseau F, Scollen S, Van Hul W, Agueda L, Akesson K, Benevolenskaya LI, Ferrari SL, Hallmans G, Hofman A, Husted LB, Kruk M, Kaptoge S, Karasik D, Karlsson MK, Lorentzon M, Masi L, McGuigan FE, Mellstrom D, Mosekilde L, Nogues X, Pols HA, Reeve J, Renner W, Rivadeneira F, van Schoor NM, Weber K, Ioannidis JP, Uitterlinden AG 2008 Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. JAMA 299:1277-1290.
75. Weedon MN, Lango H, Lindgren CM, Wallace C, Evans DM, Mangino M, Freathy RM, Perry JR, Stevens S, Hall AS, Samani NJ, Shields B, Prokopenko I, Farrall M, Dominiczak A, Johnson T, Bergmann S, Beckmann JS, Vollenweider P, Waterworth DM, Mooser V, Palmer CN, Morris AD, Ouwehand WH, Zhao JH, Li S, Loos RJ, Barroso I, Deloukas P, Sandhu MS, Wheeler E, Soranzo N, Inouye M, Wareham NJ, Caulfield M, Munroe PB, Hattersley AT, McCarthy MI, Frayling TM 2008 Genome-wide association analysis identifies 20 loci that influence adult height. Nat Genet 40:575-583.